Literature DB >> 12172334

Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia.

Bob Oranje1, Clarine J Van Oel, Christine C Gispen-De Wied, Marinus N Verbaten, René S Kahn.   

Abstract

Patients with schizophrenia show a loss of sensory (motor) gating, which is reflected in a reduced prepulse inhibition (PPI) of the startle reflex. Furthermore, patients with schizophrenia habituate less than healthy subjects. From previous studies, it is clear that typical antipsychotics have little or no effect on either sensorimotor gating or habituation, while only limited data is available on the effects of atypical antipsychotics on these processes.Forty-four schizophrenic patients (27 stable on typical and 17 stable on atypical antipsychotics) and 35 healthy control subjects were tested in a PPI paradigm. The prepulse and startle stimuli were pure tones of 1500 Hz (duration 40 ms, intensity 80 dB and 110 dB respectively), with a fixed interstimulus interval of 120 milliseconds. Block effects in PPI and startle amplitude to the pulse alone trials (habituation) were analyzed over the three groups, using comedication (i.e., benzodiazepines) as a covariate. Main effect for block was found for startle amplitude (habituation), while main effects for group and block were found for percentage PPI. Further analysis displayed significant differences in PPI between the patients treated with typical antipsychotics and the healthy control group, while patients treated with atypical antipsychotics did not differ from either the healthy control group, or the patients treated with typical antipsychotics. Furthermore, post-hoc division of the patients treated with atypical antipsychotics in patients treated with clozapine and risperidone revealed that this superiority from atypical antipsychotics over typical antipsychotics appeared to be mainly based on the effects of clozapine. Patients with schizophrenia who are treated with atypical antipsychotics appear to have levels of sensorimotor gating that are more consistent with healthy controls than patients who are treated with typical antipsychotics. Furthermore, within the class of atypical antipsychotics, clozapine appears most potent in restoring this process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12172334     DOI: 10.1097/00004714-200208000-00005

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  30 in total

Review 1.  The stress-vulnerability hypothesis in psychotic disorders: focus on the stress response systems.

Authors:  Christine C Gispen-de Wied; Lucres M C Jansen
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 2.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

3.  Effects of haloperidol and clozapine on sensorimotor gating deficits induced by 5-hydroxytryptamine depletion in the brain.

Authors:  Snezana Kusljic; Jan Brosda; Maarten van den Buuse
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

4.  Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.

Authors:  Signe Düring; Birte Y Glenthøj; Gitte Saltoft Andersen; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2014-07-23       Impact factor: 7.853

5.  Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.

Authors:  Wendy Hasenkamp; Michael P Epstein; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2010-05-16       Impact factor: 3.222

6.  Profile of auditory information-processing deficits in schizophrenia.

Authors:  Bruce I Turetsky; Warren B Bilker; Steven J Siegel; Christian G Kohler; Raquel E Gur
Journal:  Psychiatry Res       Date:  2008-11-06       Impact factor: 3.222

Review 7.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

8.  Prepulse inhibition in fragile X syndrome: feasibility, reliability, and implications for treatment.

Authors:  David Hessl; Elizabeth Berry-Kravis; Lisa Cordeiro; Jennifer Yuhas; Edward M Ornitz; Aaron Campbell; Elizabeth Chruscinski; Crystal Hervey; James M Long; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

9.  Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801.

Authors:  Naoe Okamura; Rainer K Reinscheid; Shintaro Ohgake; Masaomi Iyo; Kenji Hashimoto
Journal:  Neuropharmacology       Date:  2009-07-02       Impact factor: 5.250

10.  Uncontrollable voices and their relationship to gating deficits in schizophrenia.

Authors:  Veena Kumari; Emmanuelle R Peters; Dominic Fannon; Preethi Premkumar; Ingrid Aasen; Michael A Cooke; Anantha P Anilkumar; Elizabeth Kuipers
Journal:  Schizophr Res       Date:  2008-02-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.